Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine

被引:21
作者
Balamane, Maya [1 ]
Varghese, Vici [1 ]
Melikian, George L. [1 ]
Fessel, W. Jeffrey [2 ]
Katzenstein, David A. [1 ]
Shafer, Robert W. [1 ]
机构
[1] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[2] Kaiser Permanente Med Care Program No Calif, San Francisco, CA USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; DRUG-RESISTANCE; WILD-TYPE; HIV-1; PATTERNS; FITNESS;
D O I
10.1128/AAC.00648-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We created a panel of 10 representative multi-nonnucleoside reverse transcriptase inhibitor (NNRTI)-resistant recombinant infectious molecular HIV-1 clones to assist researchers studying NNRTI resistance or developing novel NNRTIs. The cloned viruses contain most of the major NNRTI resistance mutations and most of the significantly associated mutation pairs that we identified in two network analyses. Each virus in the panel has intermediate- or high-level resistance to all or three of the four most commonly used NNRTIs.
引用
收藏
页码:4522 / 4524
页数:3
相关论文
共 15 条
[1]   TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1 [J].
Azijn, Hilde ;
Tirry, Ilse ;
Vingerhoets, Johan ;
de Bethune, Marie-Pierre ;
Kraus, Guenter ;
Boven, Katia ;
Jochmans, Dirk ;
Van Craenenbroeck, Elke ;
Picchio, Gaston ;
Rimsky, Laurence T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (02) :718-727
[2]   Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants [J].
Das, K ;
Clark, AD ;
Lewi, PJ ;
Heeres, J ;
de Jonge, MR ;
Koymans, LMH ;
Vinkers, HM ;
Daeyaert, F ;
Ludovici, DW ;
Kukla, MJ ;
De Corte, B ;
Kavash, RW ;
Ho, CY ;
Ye, H ;
Lichtenstein, MA ;
Andries, K ;
Pauwels, R ;
de Béthune, MP ;
Boyer, PL ;
Clark, P ;
Hughes, SH ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2550-2560
[3]  
Ghosn J, 2009, AIDS REV, V11, P165
[4]   Relative replication fitness of a high-level 3′-azido-3′-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr→Gly) at codon 69 [J].
Imamichi, T ;
Berg, SC ;
Imamichi, H ;
Lopez, JC ;
Metcalf, JA ;
Falloon, J ;
Lane, HC .
JOURNAL OF VIROLOGY, 2000, 74 (23) :10958-10964
[5]  
JOHNSTON E, 2005, 17 INT AIDS C MEX CI, V19, P731
[6]   Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environments [J].
Martins, Joao Z. R. ;
Chappey, Colombe ;
Haddad, Mojgan ;
Whitcomb, Jeannette M. ;
Stawiski, Eric ;
Petropoulos, Christos J. ;
Bonhoeffer, Sebastian .
EPIDEMICS, 2010, 2 (02) :85-91
[7]   A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 [J].
Petropoulos, CJ ;
Parkin, NT ;
Limoli, KL ;
Lie, YS ;
Wrin, T ;
Huang, W ;
Tian, H ;
Smith, D ;
Winslow, GA ;
Capon, DJ ;
Whitcomb, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :920-928
[8]   Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations [J].
Reuman, Elizabeth C. ;
Rhee, Soo-Yon ;
Holmes, Susan P. ;
Shafer, Robert W. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (07) :1477-1485
[9]   HIV-1 subtype B protease and reverse transcriptase amino acid covariation [J].
Rhee, Soo-Yon ;
Liu, Tommy F. ;
Holmes, Susan P. ;
Shafer, Robert W. .
PLOS COMPUTATIONAL BIOLOGY, 2007, 3 (05) :836-843
[10]   Genotypic predictors of human immunodeficiency virus type 1 drug resistance [J].
Rhee, Soo-Yon ;
Taylor, Jonathan ;
Wadhera, Gauhar ;
Ben-Hur, Asa ;
Brutlag, Douglas L. ;
Shafer, Robert W. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) :17355-17360